http://www.feedburner.comInstitute of Medicine RSS feed for the following topic: DiseasesThe National Academy of Medicine’s Annual Meeting (October 19, 2015) on Aging: Complexities, Opportunities, And Impacts on Society will explore this topic from a variety of perspectives and should make for a lively and worthwhile exchange.http://www.iom.edu/Activities/PublicHealth/AnnualMeeting/2015-OCT-19.aspx6/25/2015Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.http://www.iom.edu/Reports/2010/Sex-Differences-and-Implications-for-Translational-Neuroscience-Research.aspx6/24/2015Millions of people in sub-Saharan Africa suffer from mental, neurological, and substance use (MNS) disorders, and most do not have the resources to obtain treatment. The Uganda National Academy of Sciences and the IOM hosted a workshop to discuss the state of care for MNS disorders in sub-Saharan Africa.http://www.iom.edu/Reports/2010/Mental-Neurological-and-Substance-Use-Disorders-in-Sub-Saharan-Africa-Reducing-the-Treatment-Gap-Increasing-Quality-of-Care.aspx6/24/2015Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer’s, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The IOM’s Forum on Neuroscience and Nervous System Disorders held a workshop June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers.http://www.iom.edu/Reports/2011/Glutamate-Related-Biomarkers-in-Drug-Development-for-Disorders-of-the-Nervous-System.aspx6/24/2015Presentation at the Alzheimer's Association International Conference on Alzheimer's Disease 2011 http://www.iom.edu/Activities/Research/NeuroForum/2011-JUL-18.aspx6/24/2015The goal of the workshop was to present promising current and emerging technologies with potential as reliable glutamate biomarkers, and to outline strategies to accelerate development, validation, and implementation of these biomarkers as powerful tools to advance drug development for nervous system disorders associated with glutamatergic dysfunction.http://www.iom.edu/Activities/Research/NeuroForum/2010-JUN-21.aspx6/24/2015This IOM workshop will examine the clinical benefits and comparative effectiveness of emerging advanced technologies for cancer treatment in radiation therapy and surgery. Workshop participants will discuss current utilization patterns, with a focus on diffusion of new technologies into oncology practice, as well as evidence on the overuse, underuse, and misuse of these technologies, and potential strategies to assess the value and define optimal use of new technologies in cancer treatment.http://www.iom.edu/Activities/Disease/NCPF/2015-JUL-20.aspx6/23/2015On June 25, 2008, the IOM Forum on Neuroscience and Nervous System Disorders hosted more than 70 of the leading neuroscientists in the world, for a workshop titled From Molecules to Minds: Challenges for the 21st Century. The objective of the workshop was to explore a set of common goals or “Grand Challenges” posed by participants that could inspire and rally both the scientific community and the public to consider the possibilities for neuroscience in the 21st century.http://www.iom.edu/Reports/2008/From-Molecules-to-Minds-Challenges-for-the-21st-Century.aspx6/23/2015This workshop, hosted by the National Cancer Policy Forum, will examine the rationale and potential for integrating clinical trials for pets with naturally occurring cancers into translational cancer research and development. It will also highlight potential opportunities to overcome existing challenges.http://www.iom.edu/Activities/Disease/NCPF/2015-JUN-08.aspx6/10/2015The first workshop in a two-part series on cancer care in low resource areas. The first workshop will focus on cancer prevention and early detection.http://www.iom.edu/Activities/Disease/NCPF/2015-OCT-26.aspx6/5/2015http://www.iom.edu/Activities/PublicHealth/ReduceVisionImpairment/2015-MAY-19-20.aspx6/4/2015The first meeting of the Committee on the State of the Science in Ovarian Cancer Research will take place January 8, 2015, at the Keck Center Building. There will be intermittent open and closed sessions. Please see agenda for details.http://www.iom.edu/Activities/Women/OvarianCancerResearch/2015-JAN-08.aspx6/2/2015The Committee on the State of the Science of Ovarian Cancer Research, as well as outside speakers, will lead an open session on April 7 and a closed session on April 8. http://www.iom.edu/Activities/Women/OvarianCancerResearch/2015-APR-7.aspx6/2/2015The third meeting of the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies will take place on June 11-12 in Room 106 of the Keck Center in Washington, DC. The open session will begin at 9:00 am and adjourn at 11:30 am on June 11 and will be conducted exclusively via WebEx. The meeting will be closed in its entirety on June 12. If you wish to call in, please register through this page.http://www.iom.edu/Activities/Research/BiomarkersforMolecularlyTargetedTherapies/2015-JUN-11.aspx5/28/2015The IOM's Forum on Neuroscience and Nervous System Disorders focuses on building partnerships to further understand the brain and nervous system, disorders in their structure and function, as well as effective clinical prevention and treatment strategies.http://www.iom.edu/Activities/Research/NeuroForum.aspx5/27/2015An ad hoc committee under the auspices of the Institute of Medicine will review the state of the science in ovarian cancer and formulate recommendations for action to advance the field. http://www.iom.edu/Activities/Women/OvarianCancerResearch.aspx5/27/2015More than 1.2 billion people worldwide play video games (online, via console, mobile phone, and other wireless devices), and many may be unaware that programmers often incorporate neuroscience into game design. Given the high prevalence of gaming in today’s society, the Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders hosted the Social Issues Roundtable at the Society for Neuroscience annual meeting on November 16, 2014, in Washington, DC, to explore the neuroscience of video games, with emphasis on relevant scientific, ethical,and societal issues.http://www.iom.edu/Reports/2015/Neuroscience-Gaming-WIB.aspx5/26/2015The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. http://www.iom.edu/Global/News Announcements/NAS-NAM-Human-Gene-Editing.aspx5/18/2015The Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases will hold a public comment period in Washington, DC on May 19.http://www.iom.edu/Activities/Research/MitoEthics/2015-MAY-19.aspx5/14/2015Through invited presentations and panel discussions, this workshop hosted by the NCPF and the American Cancer Society (ACS) will examine recent trends in comprehensive cancer care for pediatric cancer patients and their families and consider potential policy actions to improve care and outcomes. Participants will review existing evidence and efforts for integrating pediatric palliative care and quality of life strategies in childhood oncology research and practice, and will discuss additional research needed to minimize toxicities of pediatric cancer treatments and the resultant symptoms and late effects. A major goal of the workshop will be to facilitate discussion about potential strategies and actions for effectively applying existing evidence and quality of life strategies into pediatric oncology research, development, and practice. http://www.iom.edu/Activities/Disease/NCPF/2015-MAR-09.aspx5/14/2015The workshop, hosted by the NCPF and sponsored by the American Cancer Society, will review the state of the evidence regarding interpretive performance in mammography, identify remaining gaps, and consider potential opportunities for advancing research and practice.http://www.iom.edu/Activities/Disease/NCPF/2015-MAY-12.aspx5/13/2015The Institute of Medicine will conduct a consensus study to examine the core principles and public health strategies to reduce visual impairment and promote eye health in the United States. The study will describe limitations and opportunities to improve vision and eye health surveillance; reduce vision and eye health disparities; promote evidence-based strategies to improve knowledge, access and utilization to eye care; identify comorbid conditions and characterize their impact; and promote health for people with vision impairment. The study will also examine the potential for public and private collaborations at the community, state, and national levels to elevate vision and eye health as a public health issue.http://www.iom.edu/Activities/PublicHealth/ReduceVisionImpairment.aspx5/1/2015On March 24th and 25th (2015) the IOM’s Forum on Microbial Threats will convene a public workshop on the “Ebola Epidemic in West Africa.” The public workshop will feature invited presentations and discussions that will focus on such potential topics as: the source(s) and spread of this disease from its epicenter to other countries in West Africa; factors driving the unprecedented scale of this outbreak; factors impeding country responses; and opportunities to mobilize the domestic and international health communities in a coordinated response to this dread disease to stop the geographic spread of this disease. The meeting is free and open to the public but registration is required. http://www.iom.edu/Activities/PublicHealth/MicrobialThreats/2015-MAR-24.aspx4/27/2015The National Cancer Policy Forum considers critical issues in science, clinical medicine, public health, and public policy relevant to the goals of preventing and treating cancer. http://www.iom.edu/Activities/Disease/NCPF.aspx4/27/2015The Forum on Microbial Threats, the premier convening activity of the IOM, provides a neutral venue for stakeholder discussion and scrutiny of critical issues on the research, surveillance, detection and response to the evolving disease threats of humans, plants, and animals.http://www.iom.edu/Activities/PublicHealth/MicrobialThreats.aspx4/23/2015The Institute of Medicine Releases a new Workshop Summary: Developing a 21st Century Neuroscience Workforce: Workshop Summaryhttp://www.iom.edu/Activities/Research/NeuroForum/Training Report.aspx4/21/2015An IOM committee will host a 2-day workshop in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to essential medicines for MNS disorders.http://www.iom.edu/Activities/Research/NeuroForum/2014-JAN-13.aspx4/21/2015Given the changing landscape resulting from technological advances and the growing importance of interdisciplinary and collaborative science, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders convened a workshop on October 28 and 29, 2014, in Washington, DC, to explore future workforce needs and how these needs should inform training programs.http://www.iom.edu/Reports/2015/21st-Century-Neuroscience-Workforce.aspx4/21/2015Given the pressing need for progress in the field, this workshop will bring together key stakeholders from industry, government agencies like NIH and FDA, academia and patient advocacy groups to discuss opportunities for advancing drug development for dry AMD. http://www.iom.edu/Activities/Research/NeuroForum/2014-NOV-15.aspx4/20/2015An ad hoc committee, under the auspices of the Institute of Medicine in collaboration with the National Research Council will organize a one-day workshop that will explore potential research priorities arising as a result of the emergence of Ebola Virus Disease (EVD), a hemorrhagic disease caused by a filovirus, in the United States.http://www.iom.edu/Activities/PublicHealth/EbolaTransmissionResearch/2014-NOV-03.aspx4/20/2015